[1] Gluckman E, Broxmeyer HA, Auerbach AD,et al. Hematopoietic reconstitution in a patient with Fanconi's anemia by means of umbilical-cord blood from an HLA-identical sibling. N Engl J Med. 1989;321(17):1174- 1178.[2] Erices A, Conget P, Minguell JJ. Mesenchymal progenitor cells in human umbilical cord blood. Br J Haematol. 2000; 109(1):235-242.[3] Lee OK, Kuo TK, Chen WM,et al. Isolation of multipotent mesenchymal stem cells from umbilical cord blood. Blood. 2004;103(5):1669-1675.[4] Wu LF, Wang NN, Liu YS,et al. Differentiation of Wharton's jelly primitive stromal cells into insulin-producing cells in comparison with bone marrow mesenchymal stem cells. Tissue Eng Part A. 2009;15(10):2865-2873.[5] Liu H, Rich ES, Godley L,et al. Reduced-intensity conditioning with combined haploidentical and cord blood transplantation results in rapid engraftment, low GVHD, and durable remissions. Blood. 2011;118(24):6438-6445.[6] Prather WR, Toren A, Meiron M. Placental-derived and expanded mesenchymal stromal cells (PLX-I) to enhance the engraftment of hematopoietic stem cells derived from umbilical cord blood. Expert Opin Biol Ther. 2008;8(8):1241-1250.[7] Taghizadeh RR, Cetrulo KJ, Cetrulo CL.Wharton's Jelly stem cells: future clinical applications. Placenta. 2011;32 Suppl 4: S311-315.[8] Garzón I, Pérez-Köhler B, Garrido-Gómez J, et al. Evaluation of the Cell Viability of Human Wharton's Jelly Stem Cells for Use in Cell Therapy.Tissue Eng Part C Methods. 2012. [Epub ahead of print][9] Haylock DN, Nilsson SK. Expansion of umbilical cord blood for clinical transplantation. Curr Stem Cell Res Ther. 2007; 2(4):324-333.[10] Muraglia A, Cancedda R, Quarto R. Clonal mesenchymal progenitors from human bone marrow differentiate in vitro according to a hierarchical model. J Cell Sci. 2000;113 ( Pt 7):1161-1166.[11] Aldahmash A, Zaher W, Al-Nbaheen M,et al. Human stromal (mesenchymal) stem cells: basic biology and current clinical use for tissue regeneration. Ann Saudi Med. 2012;32(1):68-77.[12] Zhang J, Niu C, Ye L,et al. Identification of the haematopoietic stem cell niche and control of the niche size. Nature. 2003; 425(6960):836-841.[13] Balduino A, Hurtado SP, Frazão P,et al. Bone marrow subendosteal microenvironment harbours functionally distinct haemosupportive stromal cell populations.Cell Tissue Res. 2005;319(2):255-266.[14] 郝牧,李斯丹,吴瞳,等.间充质干细胞对脐血CD34+细胞扩增及其细胞特性变化的影响[J].中国实验血液学杂志,2008,16(6): 1403-1407.[15] de Barros AP, Takiya CM, Garzoni LR,et al. Osteoblasts and bone marrow mesenchymal stromal cells control hematopoietic stem cell migration and proliferation in 3D in vitro model. PLoS One. 2010;5(2):e9093.[16] Ball LM, Bernardo ME, Roelofs H,et al. Cotransplantation of ex vivo expanded mesenchymal stem cells accelerates lymphocyte recovery and may reduce the risk of graft failure in haploidentical hematopoietic stem-cell transplantation. Blood. 2007;110(7):2764-2767.[17] Le Blanc K, Frassoni F, Ball L,et al. Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study. Lancet. 2008;371(9624):1579-1586.[18] Guo CJ, Gao Y, Hou D,et al. Preclinical transplantation and safety of HS/PCs expanded from human umbilical cord blood.World J Stem Cells. 2011;3(5):43-52.[19] Xu LH, Fang JP, Hong DL,et al. Application of mesenchymal stromal cells in bone marrow transplantation for sensitized recipients. Acta Haematol. 2012;127(2):105-109.[20] Baksh D, Song L, Tuan RS. Adult mesenchymal stem cells: characterization, differentiation, and application in cell and gene therapy. J Cell Mol Med. 2004;8(3):301-316.[21] Baksh D, Yao R, Tuan RS. Comparison of proliferative and multilineage differentiation potential of human mesenchymal stem cells derived from umbilical cord and bone marrow. Stem Cells. 2007;25(6):1384-1392.[22] Jang YK, Jung DH, Jung MH,et al. Mesenchymal stem cells feeder layer from human umbilical cord blood for ex vivo expanded growth and proliferation of hematopoietic progenitor cells. Ann Hematol. 2006;85(4):212-225.[23] Yim YS, Noh YH, Kim DH,et al. Correlation between the immature characteristics of umbilical cord blood-derived mesenchymal stem cells and engraftment of hematopoietic stem cells in NOD/SCID mice.Transplant Proc. 2010;42(7): 2753-2758.[24] Noh YH, Yim YS, Kim DH,et al. Correlation between chemokines released from umbilical cord blood-derived mesenchymal stem cells and engraftment of hematopoietic stem cells in nonobese diabetic/severe combined immunodeficient (NOD/SCID) mice.Pediatr Hematol Oncol. 2011;28(8):682-690.[25] Ryu CH, Park SA, Kim SM,et al. Migration of human umbilical cord blood mesenchymal stem cells mediated by stromal cell-derived factor-1/CXCR4 axis via Akt, ERK, and p38 signal transduction pathways. Biochem Biophys Res Commun. 2010; 398(1):105-110.[26] Huang GP, Pan ZJ, Jia BB,et al. Ex vivo expansion and transplantation of hematopoietic stem/progenitor cells supported by mesenchymal stem cells from human umbilical cord blood. Cell Transplant. 2007;16(6):579-585.[27] Cheng L, Qasba P, Vanguri P,et al. Human mesenchymal stem cells support megakaryocyte and pro-platelet formation from CD34(+) hematopoietic progenitor cells. J Cell Physiol. 2000;184(1):58-69.[28] 姜尔烈,周征,黄勇,等.骨髓间充质干细胞的黏附分子表达及其对脐血造血干细胞扩增的支持作用[J].临床血液学杂志,2005, 18(5):262-265.[29] 霍思维,苏永锋,刘元林,等.人胎盘间充质干细胞对脐血CD34+细胞迁移作用的影响[J].中国科学:生命科学,2010,40(5): 399-407.[30] Kedong S, Xiubo F, Tianqing L,et al. Simultaneous expansion and harvest of hematopoietic stem cells and mesenchymal stem cells derived from umbilical cord blood. J Mater Sci Mater Med. 2010;21(12):3183-3193.[31] 周敦华,黄绍良,黄科,等.人脐血间充质干细胞促进脐血CD34+细胞在NOD/SCID小鼠体内植入的实验研究[J].中华血液学杂志,2005,26(12):732-735.[32] Hao M, Meng HX, Li G,et al. Study of influence of umbilical cord mesenchymal stem cells on CD34+ cells in vivo homing in NOD/SCID. Zhonghua Xue Ye Xue Za Zhi. 2009;30(2): 103-106.[33] Van Overstraeten-Schlögel N, Beguin Y, Gothot A. Role of stromal-derived factor-1 in the hematopoietic-supporting activity of human mesenchymal stem cells. Eur J Haematol. 2006;76(6):488-493.[34] Noort WA, Kruisselbrink AB, in't Anker PS,et al. Mesenchymal stem cells promote engraftment of human umbilical cord blood-derived CD34(+) cells in NOD/SCID mice.Exp Hematol. 2002;30(8):870-878.[35] 袁晓莉,孟恒星,郝牧.脐带间充质干细胞对脐血CD34+细胞体外扩增的影响[J].中国组织工程研究与临床康复,2009,13(14): 2645-2650. |